Neurogene Inc. (NASDAQ: NGNE) Stock Information | RedChip

Neurogene Inc. (NASDAQ: NGNE)


$18.0350
+2.4450 ( +16.51% ) 360.5K

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Market Data


Open


$18.0350

Previous close


$15.5900

Volume


360.5K

Market cap


$231.59M

Day range


$14.6970 - $18.3980

52 week range


$12.4900 - $74.4900

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Mar 14, 2024
4 Insider transactions 1 Mar 14, 2024
8-k 8K-related 52 Mar 04, 2024
8-k 8K-related 14 Feb 21, 2024
4 Insider transactions 2 Jan 18, 2024
4 Insider transactions 2 Jan 18, 2024
4 Insider transactions 1 Jan 18, 2024
4 Insider transactions 1 Jan 18, 2024
3 Insider transactions 2 Jan 18, 2024
4 Insider transactions 1 Jan 18, 2024

Latest News